84 related articles for article (PubMed ID: 32705239)
1. Targeted PLK1 suppression through RNA interference mediated by high-fidelity Cas13d mitigates osteosarcoma progression via TGF-β/Smad3 signalling.
Yuan Y; Cao D; Zhang A; Liu Z; Deng Z; Zhang S
J Cell Mol Med; 2024 May; 28(10):e18400. PubMed ID: 38780513
[TBL] [Abstract][Full Text] [Related]
2. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.
Xie X; Chauhan GB; Edupuganti R; Kogawa T; Park J; Tacam M; Tan AW; Mughees M; Vidhu F; Liu DD; Taliaferro JM; Pitner MK; Browning LS; Lee JH; Shen Y; Wang J; Ueno NT; Krishnamurthy S; Hortobagyi GN; Tripathy D; Van Laere SJ; Bartholomeusz G; Dalby KN; Bartholomeusz C
Cancer Res Commun; 2023 Jun; 3(6):1078-1092. PubMed ID: 37377604
[TBL] [Abstract][Full Text] [Related]
3. Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer.
Lee IH; Lee SJ; Kang B; Lee J; Jung JH; Park HY; Park JY; Park NJ; Kim EA; Kang J; Chae YS
Breast Cancer Res Treat; 2024 May; 205(1):181-191. PubMed ID: 38279017
[TBL] [Abstract][Full Text] [Related]
4. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
5. Up-Regulation of MELK Promotes Cell Growth and Invasion by Accelerating G1/S Transition and Indicates Poor Prognosis in Lung Adenocarcinoma.
Ni Q; Miao Y; Li X; Yin Z; Huang H; Shi G; Shi W
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38676754
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
Zhang N; Han Y; Cao H; Wang Q
J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
[TBL] [Abstract][Full Text] [Related]
7. A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers.
Zhou L; Zheng S; Rosas Bringas FR; Bakker B; Simon JE; Bakker PL; Kazemier HG; Schubert M; Roorda M; van Vugt MATM; Chang M; Foijer F
G3 (Bethesda); 2021 Dec; 11(12):. PubMed ID: 34550356
[TBL] [Abstract][Full Text] [Related]
8. The role of programmed cell death in osteosarcoma: From pathogenesis to therapy.
Liu S; Liu C; Wang Y; Chen J; He Y; Hu K; Li T; Yang J; Peng J; Hao L
Cancer Med; 2024 May; 13(10):e7303. PubMed ID: 38800967
[TBL] [Abstract][Full Text] [Related]
9. Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.
Wang D; Zou F; Li Y; Hu J; Gao L
Mol Ther Oncol; 2024 Mar; 32(1):200759. PubMed ID: 38596298
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the regulation of maternal embryonic leucine zipper kinase.
Cao LS; Wang J; Chen Y; Deng H; Wang ZX; Wu JW
PLoS One; 2013; 8(7):e70031. PubMed ID: 23922895
[TBL] [Abstract][Full Text] [Related]
11. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract][Full Text] [Related]
12. Computational insights into the binding of IN17 inhibitors to MELK.
Harger M; Lee JH; Walker B; Taliaferro JM; Edupuganti R; Dalby KN; Ren P
J Mol Model; 2019 May; 25(6):151. PubMed ID: 31069524
[TBL] [Abstract][Full Text] [Related]
13. Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
Chen Y; Cao Y; Wu S; Cao X; Cai T; Hu H
J Gene Med; 2024 Jan; 26(1):e3586. PubMed ID: 37655535
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression.
Watanabe K; Tasaka K; Ogata H; Kato S; Ueno H; Umeda K; Isobe T; Kubota Y; Sekiguchi M; Kimura S; Sato-Otsubo A; Hiwatari M; Ushiku T; Kato M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Gene Ther; 2024 Apr; ():. PubMed ID: 38622340
[TBL] [Abstract][Full Text] [Related]
15. KAT7 serves as an oncogenic gene and regulates CCL3 expression via STAT1 signaling in osteosarcoma.
Yuan Q; Wu Y; Xue C; Zhao D; Wang H; Shen Y
Biochem Biophys Res Commun; 2024 May; 722():150156. PubMed ID: 38797155
[TBL] [Abstract][Full Text] [Related]
16. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer.
Xie X; Chauhan GB; Edupuganti R; Kogawa T; Park J; Tacam M; Tan AW; Mughees M; Vidhu F; Liu DD; Taliaferro JM; Pitner MK; Browning LS; Lee JH; Bertucci F; Shen Y; Wang J; Ueno NT; Krishnamurthy S; Hortobagyi GN; Tripathy D; Van Laere SJ; Bartholomeusz G; Dalby KN; Bartholomeusz C
Cancer Res Commun; 2024 Jan; 4(1):236. PubMed ID: 38282551
[No Abstract] [Full Text] [Related]
17. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function.
Li Z; Zhou H; Zhai X; Gao L; Yang M; An B; Xia T; Du G; Li X; Wang W; Jin B
Cell Death Dis; 2023 Nov; 14(11):733. PubMed ID: 37949877
[TBL] [Abstract][Full Text] [Related]
18. Microtubule affinity regulating kinase 4 promoted activation of the NLRP3 inflammasome-mediated pyroptosis in periodontitis.
Wang L; Pu W; Wang C; Lei L; Li H
J Oral Microbiol; 2022; 14(1):2015130. PubMed ID: 34992737
[TBL] [Abstract][Full Text] [Related]
19. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
